United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - canakinumab - powder for solution for injection - 150mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - secukinumab - solution for injection - 150mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - secukinumab - solution for injection - 150mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - canakinumab - solution for injection - 150mg/1ml

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - mycophenolate sodium 192.4mg eqv mycophenolic acid - enteric coated tablet - 192.4mg - mycophenolate sodium 192.4mg eqv mycophenolic acid 180mg

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - mycophenolate sodium 384.8mg eqv mycophenolic acid - tablet, film coated - 384.8 mg - mycophenolate sodium 384.8mg eqv mycophenolic acid 360 mg

United States - English - NLM (National Library of Medicine)

merial, inc. - hyaluronate sodium (unii: yse9ppt4th) (hyaluronic acid - unii:s270n0trqy) - hyaluronate sodium 10 mg in 1 ml - indications: legend injectable solution is indicated in the treatment of joint dysfunction of the carpus or fetlock in horses due to non-infectious synovitis associated with equine osteoarthritis. contraindications: there are no known contraindications for the use of legend solution in horses.

United States - English - NLM (National Library of Medicine)

merial, inc. - hyaluronate sodium (unii: yse9ppt4th) (hyaluronic acid - unii:s270n0trqy) - indications: legend injectable solution is indicated in the treatment of joint dysfunction of the carpus or fetlock in horses due to non-infectious synovitis associated with equine osteoarthritis. contraindications: there are no known contraindications for the use of legend solution in horses.

United States - English - NLM (National Library of Medicine)

boehringer ingelheim animal health usa inc. - hyaluronate sodium (unii: yse9ppt4th) (hyaluronic acid - unii:s270n0trqy) - indications: legend injectable solution is indicated in the treatment of joint dysfunction of the carpus or fetlock in horses due to non-infectious synovitis associated with equine osteoarthritis. contraindications: there are no known contraindications for the use of legend solution in horses.

United States - English - NLM (National Library of Medicine)

boehringer ingelheim animal health usa inc - hyaluronate sodium (unii: yse9ppt4th) (hyaluronic acid - unii:s270n0trqy) - indications: legend injectable solution is indicated in the treatment of joint dysfunction of the carpus or fetlock in horses due to non-infectious synovitis associated with equine osteoarthritis. contraindications: there are no known contraindications for the use of legend solution in horses.